DRC Ebola vaccine trial to test Ervebo’s cross-protection against Bundibugyo, with upcoming Bundibugyo vaccines and Tumaini trial expansion.

The first clinical trial of an Ebola vaccine is expected to begin in the Democratic Republic of Congo by the end of October, World Health Organization experts said Tuesday.